PCNA and hepatocellular carcinoma: Furthermore, we observed that the MCT1 inhibitor α-cyano-4-hydroxycinnamate (CHC) antagonized lactate-dependent activation of Akt and subsequently PCNA expression in HCC cells (Fig. 8f).